Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marisa Chust"'
Autor:
Miguel Santos, José Luis Guinot, Maribel Tortajada, Juan Bosco Vendrell, Celia López, Alonso La Rosa, Beatriz Quiles, Marisa Chust, Alba Montaner, Leo Arribas
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 14, Iss 1, Pp 23-28 (2022)
Externí odkaz:
https://doaj.org/article/cfb4e10e0b1b437cace0ba5aec565322
Autor:
Miguel Santos, José Luis Guinot, Maribel Tortajada, Juan Bosco Vendrell, Celia López, Alonso La Rosa, Beatriz Quiles, Marisa Chust, Alba Montaner, Leo Arribas
Publikováno v:
Journal of contemporary brachytherapy. 14(1)
To analyze the results of patients treated with perioperative interstitial brachytherapy (ISBT) in tongue carcinoma (TC).From April 2009 to May 2015, 43 squamous cell carcinoma consecutive patients diagnosed with TC were treated with limited partial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2353f2fed939ce60c6ac23d468ad8ad1
https://pubmed.ncbi.nlm.nih.gov/35233231
https://pubmed.ncbi.nlm.nih.gov/35233231
Autor:
M. Murcia-Mejía, Israel Thuissard, Tamara García-Cañibano, Sara Montemuiño, Felipe Couñago, María Pilar Samper-Ots, Verónica Díaz-Díaz, María Mar Puertas, Lourdes de Ingunza-Barón, P. Calvo-Crespo, Andrés Varela, Nuria Rodríguez de Dios, Margarita Martín, J. Moradiellos, J.L. López-Guerra, María Luz Couselo, S. Amor, B. Taboada, David Sanz-Rosa, Elia del Cerro, Marisa Chust, Josep Jové-Teixidó, M. López-Mata
Publikováno v:
Rep Pract Oncol Radiother
Background: The optimal induction treatment in potentially-resectable stage IIIA-N2 NSCLC remains undefined. Aim: To compare neoadjuvant high-dose chemoradiotherapy (CRT) to neoadjuvant chemotherapy (CHT) in patients with resectable, stage IIIA-N2 no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd0362b84ec6083ba424b93317590194
https://europepmc.org/articles/PMC7244888/
https://europepmc.org/articles/PMC7244888/
Autor:
Manuel Aguayo Martos, Maribel Tortajada Azcutia, María Carrascosa Pérez, Leoncio Arribas Alpuente, María Maroñas Martín, Carmen Pesudo Ayet, Pedro Perez, Manuel Casaña Giner, José Luis Guinot Rodríguez, Inmaculada Beato Tortajada, Marisa Chust Vicente, José Luis Mengual Cloquell
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 7(9)
We evaluated the effectiveness of interstitial high dose rate brachytherapy as a single fraction boost to the surgical bed in patients with breast cancer undergoing conservative treatment. The comparison was with the alternative of electron boost.Bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7060661a7724e5c47bc8931bc22e5852
https://pubmed.ncbi.nlm.nih.gov/16238975
https://pubmed.ncbi.nlm.nih.gov/16238975